We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Ropivacaine Hydrochloride / Ropivacaine HCL
CAS No.
132112-35-7
Molecular Formula
C17H26N2O·HCl·
Molecular Weight
328.88
Quality Standard
98% up by HPLC
Appearance
White powder
COA of Ropivacaine Hydrochloride
Items
Specifications
Results
Appearance
White Powder
Complies
Assay (HPLC)
98%min
99.8%
Odor
Characteristic
Complies
Sieve analysis
100% pass 80 mesh
Complies
Heavy Metal
<10ppm
Complies
As
< 0.1ppm
0.05ppm
Pb
< 0.1ppm
0.05ppm
Cd
< 0.1ppm
0.05ppm
Residual solvents
<100ppm
Complies
Residual pesticide
Negative
Complies
Total Plate Count
< 1000 cfu/g
Complies
Yeast&Mold
< 100 cfu/g
Complies
E.Coli
Negative
Complies
Salmonella
Negative
Complies
Conclusion
Meet the specification of standards
Usage
Function of Ropivacaine Hydrochloride
Since it was discovered that long-acting local anesthetics can induce cardiac arrest, people have been seeking alternative medicines that are less fat-soluble and safer. Ropivacaine is such a new type of long-acting amide local anesthetic, which has a long duration of action, and has anesthetic and analgesic effects. Its pharmacological characteristics are low cardiotoxicity, obvious separation of sensory block and motor block, and peripheral vasoconstriction. Therefore, the drug is especially suitable for postoperative analgesia and obstetric anesthesia.
Compared with traditional local anesthetics, Ropivacaine HCL has the following advantages:
1. Curative effect: The action time of ropivacaine is significantly longer than other long-acting local anesthetics, and the action time of subcutaneous infiltration anesthesia is 2 to 3 times longer than that of bupivacaine of the same concentration.
2. Unique curative effect-the sensory-motor block separation of ropivacaine is much greater than that of bupivacaine, and the clearance rate is higher, making it more suitable for analgesia.
3. Strong controllability-the anesthetic effect of ropivacaine is dose-dependent, which means that the degree of sensory and motor block produced by ropivacaine is predictable and controllable.
4. Low toxic and side effects-Ropivacaine does not have the disadvantage of greater cardiotoxicity of general long-acting local anesthetics. Cardiotoxicity is rarely caused by this product, and the fetus has good tolerance to this product.